The NCI Small Business Programs: Supporting Cancer Start-Ups – Deepa Narayanan, Program Director, Small Business Innovation Research (SBIR) Development Center, National Cancer Institute

Funding Opportunities for Biomedical Product Development at NIDA – Victor Prikhodko, Senior Business Development Manager, National Institute on Drug Abuse

Non-Dilutive Funding Opportunities from the Defense Threat Reduction Agency – Dr. Ron Hann, Director, Chemical and Biological Technologies Department, DTRA

The NIAID SBIR/STTR Programs, Funding Opportunities, and Application Tips – Dr. Susan E. Old, Deputy Director, Division of Extramural Activity, NIAID

Part VI: Funding Opportunities

These can be divided into 2 categories: solicited and unsolicited

Unsolicited opportunities, also known as investigator-initiated or omnibus solicitations, or parent announcements are when investigators submit a solicitation with no specific solicitation. Many NIH institutes participate in the parent announcements. Approximately, two-thirds of all awards are unsolicited; even if you can’t find an exact solicitation for your project, utilize the unsolicited mechanism.

The deadlines and budget are standard for parent announcements. Recently, the NIH separated the parent announcements for clinical trials allowed and clinical trials not allowed.

Solicited opportunities, are specific opportunities for specific indications. As of 2018, there were 92 open from the NIH alone.

Part V: Standard Due Dates for SBIR/STTR Applications

The due dates for SBIR/STTR applications are cyclic:

  • January 5
  • April 5
  • June 5
  • September 5

It takes ~2 months from submission until review and score. It can take another 3-4 months to be awarded. The NIH has been working on reducing the amount of time it takes to award funds.   

It’s important to remember that some of the solicitations have non-standard due dates. Carefully read each solicitation.

Look for PART VI next week!